Tehran and Havana Forge Strategic Pharmaceutical Partnership with New MOU

Tehran and Havana Forge Strategic Pharmaceutical Partnership with New MOU

In a significant move to strengthen international cooperation in the health sector, Iran and Cuba have signed a memorandum of understanding (MOU) aimed at enhancing access to health products. This agreement, finalized between Iran’s Food and Drug Administration (FDA) and Cuba’s Center for State Control of Medicines and Medical Devices (CECMED), is set to create a more integrated framework for pharmaceutical manufacturing and distribution between the two nations.

The MOU, reported by Mehr news agency, outlines key provisions that will facilitate the mutual recognition of pharmaceutical companies and products. Here are the essential elements of the agreement:

  • Recognition of Licensed Companies: Companies and manufacturing centers licensed in one country will be recognized in the other.
  • Registration of Products: Pharmaceutical products and medical equipment produced by either party will be registered and approved in the other country.
  • Streamlined Certification Process: Official registration certificates for existing and new products will be issued within a month, eliminating the need for re-evaluation.

This streamlined process is designed to enhance market access for health products in both countries, paving the way for a more robust health sector collaboration.

In addition to the recognition of companies and products, the MOU also includes provisions for:

  • Joint Educational Courses: Collaborative educational initiatives in regulatory affairs.
  • Knowledge Sharing: Exchange of technical, engineering, and biological expertise for the construction and equipping of factories.

This strategic agreement marks a pivotal step toward expanding scientific, technological, and economic ties between Iran and Cuba, particularly in the health sector. It lays the groundwork for engaging in educational and research projects, focusing on:

  • Vaccine Development: Collaboration in developing vaccines and biological products.
  • Laboratory Diagnostic Techniques: Enhancing laboratory capabilities and diagnostic methods.

Joint efforts to enhance medical cooperation also took place in September when Ali Jafarian, senior advisor to the Iranian health minister, met with Tania Margarita Cruz Hernandez, Cuba’s Acting Minister of Public Health. During this meeting, they explored ways to bolster medical and scientific ties, specifically in vaccine production and biotechnology.

The discussions revolved around the implementation of previously reached agreements between the two countries. They aimed to promote scientific and technical collaboration with the Pasteur Institute, focusing on the transfer of pneumococcal vaccine production technology from the Finlay Institute of Vaccines in Cuba. Potential capacities for manufacturing the vaccine were also examined, showcasing the commitment both nations have towards advancing health technology.

In addition to the pivotal discussions held with Cruz Hernandez, Jafarian also engaged with various Cuban officials, including:

  • Deputy Minister of Foreign Affairs
  • Deputy Minister of Foreign Trade and Investment
  • Directors of the Center for State Control of Medicines and Medical Devices (CECMED)
  • Officials from the Finlay Institute of Vaccines
  • Center for Genetic Engineering and Biotechnology (CIGB)
  • BioCubaFarma
  • Cuban Center of Molecular Immunology (CIM)
  • Hermanos Ameijeiras Hospital, the largest hospital in Cuba

Medical ties between Iran and Cuba have a rich history, dating back over three decades. The initial collaboration focused on the transfer of technology for manufacturing the hepatitis B vaccine from Cuba’s CIGB to the Pasteur Institute of Iran. More recently, the two countries successfully developed a Covid-19 vaccine known as PastoCovac, and efforts to transfer technology for the pneumococcal vaccine are currently in progress.

According to Jafarian, Cuba stands out as one of the Latin American countries with the highest level of cooperation with Iran across various fields, particularly in healthcare. He emphasized, “Thanks to advanced technologies in Cuba, the two countries have benefited from collaborative partnerships in the health sector, such as developing vaccines,” as reported by IRNA.

This memorandum of understanding not only signifies a shared commitment to improving health outcomes but also establishes a foundation for future collaborations that could significantly impact public health in both Iran and Cuba. By leveraging each other’s strengths and expertise, both nations have the potential to enhance their healthcare systems and contribute to global health advancements.

Similar Posts